Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether]: Reversal by a specific antagonist, BN 52021

CV-3988 - A specific antagonist of platelet activating factor (PAF)

Zen‐ichi Terashita, Susumu Tsushima, YOSHIO YOSHIOKA et al. · Life Sciences · 1983 · 336 citations

Medicine, Hematology, Pharmacology +12

Specific binding of phospholipid platelet-activating factor by human platelets.

Frank H. Valone, Eric Coles, V R Reinhold et al. · The Journal of Immunology · 1982 · 231 citations

Life Sciences, Biochemistry, Pharmacology +17

BN 52021 and related compounds: A new series of highly specific PAF-acether receptor antagonists isolated from Ginkgo biloba L.

P. Braquet, B. Spinnewyn, M. Braquet et al. · Blood & Vessel · 1985 · 206 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

Binding kinetics of PAF-acether (1-<i>O</i>-alkyl-2-acetyl-<i>sn</i>-glycero-3-phosphocholine) to intact human platelets

E Kloprogge, J W N Akkerman · Biochemical Journal · 1984 · 125 citations

Medicine, Biochemistry, Pharmacology +15

Characteristics of the binding of platelet-activating factor to platelets of different animal species

Pedro Iñarrea, Julián Gómez-Cambronero, Mariano Sánchez Crespo · European Journal of Pharmacology · 1984 · 120 citations

Medicine, Cell Biology, Hematology +14